Joint naloxone original recombinant tissue type fibrinolytic enzyme activator in treatment of acute cerebral infarction curative effect and safety evaluation
Objective To observe the joint naloxone original recombinant tissue type fibrinolytic enzyme activator(rt-PA) in treatment of acute cerebral infarction clinical curative effect, and to assess its security. Methods Our hospital from January 2012 to February 2012 between the treated 118 patients with acute cerebral infarction were randomly divided into two groups, rt- PA group 59 patients treatment, joint 59 patients in rt-PA group, naloxone used to drugs on the basis of comparing two groups after treatment of ESS score, total effective rate, and so on and so forth. Results The combined treatment group after ESS scores and total effective rate were significantly higher than that of rt-PA group, two groups are significant difference(P<0.01); At the same time two groups of incidence of adverse reactions are lower. Conclusion Combined therapy with rt-PA naloxone in acute cerebral infarction curative effect significantly, safe and reliable, worthy of clinical popularization and application.
rt-PANaloxone in acute cerebral infarctionCurative effect and security
NETL
NSTL
万方数据
维普
